ABBV vs IT · P/E 81, rev $61.16B vs P/E 16, rev $6.27B
AbbVie Inc (ABBV) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ABBV and IT stock pages for the full models.
Not investment advice.